IgG Subclass Distribution in Serum and Various Mucosal Fluids of HIV Type 1-Infected Subjects
- 1 April 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 16 (6) , 583-594
- https://doi.org/10.1089/088922200309007
Abstract
We measured total IgG 1, IgG2, IgG3, and IgG 4 concentrations by ELISA in serum (S), total saliva (TS), cervicovaginal secretions (CVS), seminal secretions (SPE), and rectal secretions (RS) from either CDC II/III HIV1-infected subjects or healthy volunteers. Human serum albumin was measured in parallel to calculate the relative coefficient of excretion (RCE). Levels of IgG 1 and IgG 3 directed against gp120 MN also were measured by ELISA in all samples, and the specific activity (SA) calculated. HIV-1-specific IgG2 and IgG 4 were not compared, as total IgG 2 and total IgG4 levels in HIV-1-infected subjects were found to be lower than in the healthy controls. Despite substantial interindividual variability, total IgG 1 and IgG3 concentrations in all fluids were greater in the HIV-1-infected subjects than in the healthy controls. Calculations of RCE indicated predominantly a transudative origin for IgG subclasses in the different mucosal fluids, except for CVS, in which IgG1, IgG2, and IgG4 was produced locally. The transduction behavior of IgG3 in secretions appears to be different from that of other IgG subclasses. HIV-1-infected subjects were considered positive for IgG 1 and IgG3 antibodies against gp120 MN if their antibody levels exceeded the maximum titer measured in the control group. Positive levels of anti-gp120 MN IgG 1 were detected for 100% of HIV-1-infected individuals in S, CVS, and SPE, 97% in TS, and 75% in RS. Fewer subjects had positive levels of IgG3 to gp120 MN in their secretions (maximum 67% in CVS). Despite the low concentrations of total IgG 3, mean SA values for IgG 3 to gp120 M N were greater in secretions than in serum. No significant difference in the SA values for IgG 1 to gp120 MN was observed between the different fluids. Only CVS had a local production of HIV-specific IgG1 Our results highlight the importance of an HIV-specific IgG1 and IgG3 immune response in mucosal fluids from HIV-1-infected subjects.Keywords
This publication has 33 references indexed in Scilit:
- Comparison of the Distribution of IgG and IgA Antibodies in Serum and Various Mucosal Fluids of HIV Type 1-Infected SubjectsAIDS Research and Human Retroviruses, 1999
- Mucosal Immune Responses in Four Distinct Compartments of Women Infected with Human Immunodeficiency Virus Type 1: A Comparison by Site and Correlation with Clinical InformationThe Journal of Infectious Diseases, 1997
- Retroviral Vaccines: Challenges for the Developing WorldAIDS Research and Human Retroviruses, 1996
- Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotypeResearch in Virology, 1994
- Anti-gp160 IgG and IgA Antibodies Associated with a Large Increase in Total IgG in Cervicovaginal Secretions from Human Immunodeficiency Virus Type 1-Infected WomenThe Journal of Infectious Diseases, 1993
- Immunoglobulin G3-specific antibodies as a marker for early diagnosis of HIV infection in childrenAIDS, 1991
- IgG subclass responses to human immunodeficiency virus-1 antigens: Lack of IgG2 response to gp41 correlates with clinical manifestation of diseaseClinical Immunology and Immunopathology, 1991
- Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1The Pediatric Infectious Disease Journal, 1991
- Human Immunoglobulin G and Immunoglobulin G Subclasses: Biochemical, Genetic, and Clinical AspectsCritical Reviews in Clinical Laboratory Sciences, 1989
- Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A.Journal of Clinical Investigation, 1984